ArticleFrontiers in pharmacology2016

Identification of Febuxostat as a New Strong ABCG2 Inhibitor: Potential Applications and Risks in Clinical Situations.

Hiroshi Miyata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.